CBT With Disulfiram and Contingency Management
Maximizing the Efficacy of Cognitive Behavioral Therapy With Medication and Contingency Management
2 other identifiers
interventional
181
1 country
1
Brief Summary
This is a study of four treatments for chronic cocaine use and may help study participants to control their drug use. All participants will receive weekly individual cognitive behavioral therapy (CBT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Apr 2005
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2005
CompletedFirst Submitted
Initial submission to the registry
July 7, 2006
CompletedFirst Posted
Study publicly available on registry
July 11, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedResults Posted
Study results publicly available
December 3, 2014
CompletedDecember 3, 2014
November 1, 2014
5.7 years
July 7, 2006
November 12, 2014
November 26, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Cocaine Use by Self Report
Self-reports of substance use will be documented at each contact via the Substance Use Calendar. Similar to the Form-90 and the Time Line Follow-Back, which have been shown to be reliable and valid instruments for monitoring substance use and other outcomes in longitudinal studies202-204, the Substance Use Calendar allows a flexible, continuous evaluation of substance use on a daily basis.
12 weeks
Change in Cocaine Use by Urine Toxicology Results
We will use the Roche onsite TESTCUP system for detection of cocaine, methamphetamine, THC, benzodiazepenes, and opioids.
12 weeks
Study Arms (4)
Placebo
PLACEBO COMPARATORPlacebo (plus Cognitive Behavioral Therapy- CBT)
Disulfiram
ACTIVE COMPARATORDisulfiram (plus CBT)
Placebo plus Contingency Management
PLACEBO COMPARATORPlacebo plus Contingency Management for cocaine abstinence and medication compliance (in addition to CBT).
Disulfiram plus Contingency Management
ACTIVE COMPARATORDisulfiram plus Contingency Management for cocaine abstinence and medication compliance (in addition to CBT).
Interventions
Placebo plus Contingency Management for cocaine abstinence and medication compliance in addition to CBT
250mg of Disulfiram plus Contingency Management for cocaine abstinence and medication compliance plus CBT.
Eligibility Criteria
You may qualify if:
- year old
- cocaine dependent
- willing to sign consent
- willing to accept randomization to intervention
You may not qualify if:
- significant medical conditions
- psychiatric disorder with current use of prescribed psychotropic medication
- lifetime schizophrenia or bipolar disorder
- suicidality or homicidality
- unlikely to be able to complete 1 year follow up
- unable to speak or read English at a third grade level
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
APT Foundation
New Haven, Connecticut, 06510, United States
Related Publications (2)
Worhunsky PD, Stevens MC, Carroll KM, Rounsaville BJ, Calhoun VD, Pearlson GD, Potenza MN. Functional brain networks associated with cognitive control, cocaine dependence, and treatment outcome. Psychol Addict Behav. 2013 Jun;27(2):477-88. doi: 10.1037/a0029092. Epub 2012 Jul 9.
PMID: 22775772DERIVEDCarroll KM, Nich C, Shi JM, Eagan D, Ball SA. Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial. Drug Alcohol Depend. 2012 Nov 1;126(1-2):224-31. doi: 10.1016/j.drugalcdep.2012.05.019. Epub 2012 Jun 12.
PMID: 22695473DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Kathleen M. Carroll
- Organization
- Yale University School Of Medicine Department of Psychiatry
Study Officials
- PRINCIPAL INVESTIGATOR
Kathleen M. Carroll, PhD
Yale University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2006
First Posted
July 11, 2006
Study Start
April 1, 2005
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
December 3, 2014
Results First Posted
December 3, 2014
Record last verified: 2014-11